MARKETWIRE.NET

Decode Your Next Market Move

Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global Synthetic Biology market. Market segmentation includes Tool (Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism) and Technology (Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics and Other Technologies).

Find Out More About Regions, Brands, Dominant, Active & Niche Companies Covered in the Report

24 November 3:44 a.m., Silicon Valley, California - According to the new market research report, the global market for Synthetic Biology is projected to grow at a CAGR of 25.1% reach US$30.3 billion by 2027, driven by growing interest and investments in the discipline given its immense potential in various domains including medicine, agriculture, nanotechnology and industrial sector. The global Synthetic Biology market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Synthetic biology (SynBio) is an interdisciplinary science and cross-vertical platform that leverages an engineering approach to biology for designing and fabricating functions in cells with focus on producing new and improved biological systems, devices, and parts. SynBio is one among the few life science sectors gaining immense traction over the recent times, especially in the wake of the pandemic. Advancements in engineering technologies along with improvements in genome sequencing are empowering enterprises to leverage the SynBio approach and produce custom genetic constructs and reprogram living creatures, while emphasizing new methods to manufacture drugs, materials, biofuels, chemicals, and various other solutions and products. In the first half of the year 2020, over 55 synthetic biology startups raised more than US$3 billion in funding as compared to US$1.9 billion raised by 65 companies in the same period a year earlier.

Synthetic biology unfolds a new scientific era, in which synthetic organisms can be created to serve different purposes. The new biological research area is a nascent science and engineering discipline that seeks to integrate science with engineering for designing and building novel biological entities, including cells, genetic circuits and enzymes, or for redesigning active biological systems and living organisms, such as bacteria inexpensively and rapidly. Recent developments in the area of synthetic biology have been primarily powered by robotics, automation, and artificial intelligence, which have resulted in significantly reducing the cost of technology. Synthetic biology offers tremendous potential in developing solutions for transforming carbon emissions and waste streams into useful raw materials. In addition, the technology is being viewed as essential for developing and testing vaccines, diagnostics, and treatments for novel diseases, such as coronavirus. Synthetic biology holds huge potential for upending science and drug development. Corporate initiatives, investments, and consumer attitudes are expected to play a major role in defining market outcomes. The technology holds promise in multiple sectors such as preventing shortages of drug ingredients, and revitalizing agriculture.
Synthetic biology allows users to derive deep insights into DNA sequencing as well as improve food crops, produce green energy sources, find novel drugs and create bio-based chemicals. Some of the other potential environmental uses of synthetic biology include bio-transformation, innovative chemicals, biodegradation and detection of various environmental contaminants and pathogens. These applications are anticipated to help the technique in garnering significant attention from various governments. Technology advances in DNA synthesis, nano-liter scale screening, genome engineering, application of in vitro transcription, continuous and cell-free evolution formats, and machine learning and artificial intelligence are expected to widen opportunities for synthetic biology, going forwards. Investments in synthetic biology research will continue to remain crucial to the market's growth.

Research Methodology
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. The views, opinions and findings presented are based on validated engagements from a total executive pool size of 886. Among this pool, 177 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 33 unique participations, a total of 16 validated responses were received as part of this report's primary research outreach program. We are unique in the industry to provide our clients with the validated list executive engagements and the complete project data stack.

Key Competitors Covered in the Report -
OriGene Technologies, Inc.
Codexis, Inc.
Integrated DNA Technologies, Inc.
Eurofins Scientific SE
GENEWIZ
Editas Medicine, Inc.
GeneWorks Pty., Ltd.
Proterra, Inc.
Synthorx, Inc.
GenScript USA, Inc.
Synthetic Genomics, Inc.

Segments Covered in the Report -
Tool (Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA), Chassis Organism)
Technology (Nucleotide Synthesis & Sequencing, Genome Engineering, Microfluidics, Other Technologies)
Application (Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture, Environmental, Other Applications)

Geographies Analyzed in the Report -
World
USA
Canada
Japan
China
Europe
France
Germany
Italy
UK
Rest of Europe
Asia-Pacific
Rest of World.

View Executive Engagement Dashboards, COVID Impact Questionnaires & Get Complimentary Access to Methodology & Full-Text Secondary Sources

For enquiries e-mail us at sales@strategyR.com .

For cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on LinkedIn

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world`s only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.

Contact Us:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: sales@StrategyR.com